Volume 96, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, , 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93104.[Crossref] [Google Scholar]
  2. Garner P, Gulmezoglu A, , 2006. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 4: CD000169. [Google Scholar]
  3. World Health Organization (WHO), 2004. A Strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. Vol. AFR/MAL/04/01, Brazzaville, Africa: WHO Regional Office for Africa. [Google Scholar]
  4. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW, , 2012. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis 12: 942949.[Crossref] [Google Scholar]
  5. Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Shi YP, Magnussen P, Meshnick S, Ter Kuile FO, , 2016. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis 62: 323333.[Crossref] [Google Scholar]
  6. Desai M, Gutman J, L'Lanziva A, Otieno K, Juma E, Kariuki S, Ouma P, Were V, Laserson K, Katana A, Williamson J, Ter Kuile FO, , 2015. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet 386: 25072519.[Crossref] [Google Scholar]
  7. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, , 2016. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 374: 928939.[Crossref] [Google Scholar]
  8. Stoner M, Smid M, Kumwenda A, Stringer E, Chi B, Stringer J, , 2017. Dosage of sulfadoxine-pyrimethamine and risk of low birth weight in a cohort of Zambian pregnant women in a low malaria prevalence region. Am J Trop Med Hyg 96: 170177.[Crossref] [Google Scholar]
  9. Klement E, Pitché P, Kendjo E, Singo A, D'Almeida S, Akouete F, Akpaloo Y, Tossa K, Prince-Agbodjan S, Patassi A, Caumes E, , 2014. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial. Clin Infect Dis 58: 651659.[Crossref] [Google Scholar]
  10. Gonzalez R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, Aponte JJ, Bulo H, Kabanywanyi AM, Katana A, Maculuve S, Mayor A, Nhacolo A, Otieno K, Pahlavan G, Ruperez M, Sevene E, Slutsker L, Vala A, Williamsom J, Menendez C, , 2014. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med 11: e1001735.[Crossref] [Google Scholar]
  11. Dingens A, Fairfortune TS, Reed S, Mitchell C, , 2016. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth 16: 278.[Crossref] [Google Scholar]
  12. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ, , 2013. Infant antibiotic exposures and early-life body mass. Int J Obes 37: 1623.[Crossref] [Google Scholar]
  13. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ, , 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621626.[Crossref] [Google Scholar]
  14. Capan M, Mombo-Ngoma G, Makristathis A, Ramharter M, , 2010. Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J 9: 303.[Crossref] [Google Scholar]
  15. Moodley T, Moodley D, Sebitloane M, Maharaj N, Sartorius B, , 2016. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa. BMC Pregnancy Childbirth 16: 35.[Crossref] [Google Scholar]
  16. Mofeson L, , 2015. Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room? J Infect Dis 213: 10511054.[Crossref] [Google Scholar]
  17. Li N, Sando M, Spiegelman D, Hertzmark E, Liu E, Sando D, Machumi L, Chalamilla G, Fawzi W, , 2016. Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study. J Infect Dis 213: 10571064.[Crossref] [Google Scholar]
  • Received : 09 Nov 2016
  • Accepted : 11 Nov 2016
  • Published online : 11 Jan 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error